Following deal will be announced
Full Settlement for $250M and at same time acquisition at $12 a share and if for any reason sales falls through, a break up fee of $100M
This will cap RVP lawyer's fee to 30% of $250M and we get $12 a share
above is pure speculation on my side ... I think above deal structures allows maximum RVP shareholder benefit, appearance that sale was not part of settlement, protects RVP if BDX backs off from deal, and puts RVP litigation cost to a defined limit.
i welcome others suggestions
It's funny .my first sale ah was at 5.Funny there were bids a few minutes before the resumption of trading at like 13 bucks.With luck rvp will double instantly on news like oxgn
... this AM. A manual screen found this Micro cap health care stock with proprietary product and low debt. Legal settlement possibly sooner than later, and the chart looks ok at this point. Thanks to the posters here for the extra information.
Nice to see a civil board. Good luck.
Significant enough that I noticed the price/volume action in RVP on Friday. This popped up on my manual screen over the wknd, and it definitely has my interest. Even with Zoomlik's interest netted out, it's compelling. But why net Zoomlik out, he or she sounds sharp.
You said you are not a big player - and bought 20.000 shares in one day, total worth aprox 72.000$. This is great for "small player" on low liquidity share like RVP is.
I cannot say you are small or big player, or you have or not some info, but it looks like somebody knows something.
Anyway, we will see, nothing else rested to all of us than to wait - just same like until now.
03/07/2014 10:21:16 Bought 5000 RVP @ 3.5799 -17,909.49 ---
03/07/2014 13:00:48 Bought 5000 RVP @ 3.5799 -17,909.49 ---
03/07/2014 13:26:45 Bought 10000 RVP @ 3.58 -35,809.99 ---
i posted my concern on oxgn and exited quite a while ago
I am not a big player and currently like
Fridays has been a buying day on more then 1 instance .Probably on a Friday ah judge ruling or a weekend settlement announced pre market on a Monday morning
Who knew you are such a player? Great mb.Now we know 1 buyer of 20000 shares could accumulate in a 15 cent range 3.55-3.70.Did you get out of oxgn before the 25% drop the day the offering was announced?
LoL ... Don't get to hopeful .. There was 70k shares traded and I added 20k on Friday .. and I really don't have any inside clue .. i do think it is close though
Although we have had many days in which we've seen significant upward moves on high volume since the post trial hearing in January, my gut tells me that Friday's move is signaling that this saga is coming to a conclusion this week. Just a feeling that some significant buying for this company, but insignificant to be noticed anywhere else is signaling, hopefully, a satisfying conclusion to this crazy journey through our wonderful legal system coupled with the unpredictable craziness of Thomas Shaw.
Seriously, BDX's counsel is probably not pushing for an appeal since they have to much risk. Right now they can push for settlement and blame the Texas jury for ignoring the law.
LoL .. forgot about that ... BDX is a big company and lawyers don't want to get bad reputation. A settlement or buyout is victory for them. Another 2 years of litigation is not good .. What do I know? I am just an engineer
"Who wants that"? BDX's lawyers probably want to "fight fight fight" so they can run up the fees.
Still keeping my fingers crossed- have not sold a share.
Those are great points Kerrybrett! Yes, the company would be profitable with Shaw's royalties. And also, as part of BDX, the company would cut a great deal of cost from distribution and operations, making them significantly more profitable. In addition, there would be clear revenue synergy as part of BDX's distribution from a units sold perspective, and furthermore, BDX would probably be able to charge a bit more for RVP's technology, as right now RVP has to compete on price (due to its lack of distribution prowess). I agree, there is no way Shaw would give away his company for under $8.5/share, if not $10/share. At $10/share, that's only $300 million for BDX, plus $30 million in cash on the balance sheet (making it $270 million). This $270 million is significantly less its legal liability which is over $400 million with legal fees, as well as the unquantifiable opportunity cost of continuing this fight.
Well let's hope they are working on an acquisition and then we can all walk away with a bundle. I don't think Shaw would sell to BD for emotional reasons, but if he does, he's not going to give the company away. In any event, BD already wrote off the 340mm last quarter. So even if they pay more than that, they could offset the difference with a reasonable intrinsic value of RVP's business. Let's not forget that without Shaws double dipping royalties, this company would be making money, so an acquisition would be accretive to their earnings and that's not taking into account the extra business they would pick up in their hospital network by having the best safety needle on the market.